Erika S. Hue

Contest, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Proton Radiotherapy Offers Immune-Sparing Benefits in Glioblastoma Treatment.

Proton Radiotherapy Offers Immune-Sparing Benefits in Glioblastoma Treatment.

Journal: International journal of radiation oncology, biology, physics
Published: July 15, 2025

Proton radiotherapy offers immune-sparing benefits in glioblastoma treatment Proton therapy reduced radiation-induced lymphopenia.

Proton radiotherapy offers immune-sparing benefits in glioblastoma treatment Proton therapy reduced radiation-induced lymphopenia.

Journal: International journal of radiation oncology, biology, physics
Published: July 15, 2025

Distinct Molecular Profiles Underpin Mild-To-Moderate Equine Asthma Cytological Profiles.

Distinct Molecular Profiles Underpin Mild-To-Moderate Equine Asthma Cytological Profiles.

Journal: Cells
Published: October 11, 2024

Flow cytometry detection and quantification of circulating leukocyte subpopulations in mice after brain irradiation.

Flow cytometry detection and quantification of circulating leukocyte subpopulations in mice after brain irradiation.

Journal: Methods in cell biology
Published: October 11, 2024

Detection of Equine Parvovirus-Hepatitis Virus and Equine Hepacivirus in Archived Sera from Horses in France and Australia.

Detection of Equine Parvovirus-Hepatitis Virus and Equine Hepacivirus in Archived Sera from Horses in France and Australia.

Journal: Viruses
Published: May 02, 2024

A Screening Study Identified Decitabine as an Inhibitor of Equid Herpesvirus 4 That Enhances the Innate Antiviral Response.

A Screening Study Identified Decitabine as an Inhibitor of Equid Herpesvirus 4 That Enhances the Innate Antiviral Response.

Journal: Viruses
Published: March 27, 2024

Immunostimulating Effect of Inactivated Parapoxvirus Ovis on the Serological Response to Equine Influenza Booster Vaccination.

Immunostimulating Effect of Inactivated Parapoxvirus Ovis on the Serological Response to Equine Influenza Booster Vaccination.

Journal: Vaccines
Published: November 17, 2022

Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C2254 Variant.

Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C2254 Variant.

Journal: Pathogens (Basel, Switzerland)
Published: March 24, 2022

Equine Herpesvirus 1 Variant and New Marker for Epidemiologic Surveillance, Europe, 2021.

Equine Herpesvirus 1 Variant and New Marker for Epidemiologic Surveillance, Europe, 2021.

Journal: Emerging infectious diseases
Published: September 21, 2021

Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes.

Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes.

Journal: Vaccine
Published: December 10, 2020

Screening of potential antiviral molecules against equid herpesvirus-1 using cellular impedance measurement: Dataset of 2,891 compounds.

Screening of potential antiviral molecules against equid herpesvirus-1 using cellular impedance measurement: Dataset of 2,891 compounds.

Journal: Data in brief
Published: September 11, 2020

Identification of a New Equid Herpesvirus 1 DNA Polymerase (ORF30) Genotype with the Isolation of a C2254/H752 Strain in French Horses Showing no Major Impact on the Strain Behaviour.

Identification of a New Equid Herpesvirus 1 DNA Polymerase (ORF30) Genotype with the Isolation of a C2254/H752 Strain in French Horses Showing no Major Impact on the Strain Behaviour.

Journal: Viruses
Published: September 09, 2020
Showing 1-12 of 25

Last Updated: 09/26/2026